The USAID Office of Inspector General, Financial Audits Division, is initiating an audit of MCC’s financial statements, internal controls over financial reporting, and compliance for the fiscal year ending September 30, 2026. The audit objectives are to (1) express an opinion on whether MCC’s financial statements as of September 30, 2026, were presented fairly, in all material respects; (2) evaluate MCC’s internal controls over financial reporting; and (3) determine whether MCC complied with applicable laws, regulations, contracts, and grant agreements.

The USAID Office of Inspector General (OIG) is proud to announce the signing of a Memorandum of Understanding (MoU) with the National Association of Boards of Pharmacy (NABP). “This MoU will strengthen USAID OIG’s investigations into diversion, fraud, and other risks to the pharmaceutical supply chain by leveraging technology to improve visibility, oversight, and coordinated action against the misuse or theft of U.S.-funded global health commodities worldwide,” said Sean M. Bottary, Acting Assistant Inspector General for Investigations.